Sharon Barber-Lui Email & Phone Number
@merck.com
LinkedIn matched
Who is Sharon Barber-Lui? Overview
A concise factual answer block for searchers comparing this professional profile.
Sharon Barber-Lui is listed as Chief Financial Officer and Senior Vice President, North America at Teva Pharmaceuticals, based in New York City Metropolitan Area, United States. AeroLeads shows a work email signal at merck.com and a matched LinkedIn profile for Sharon Barber-Lui.
Sharon Barber-Lui previously worked as Chief Financial Officer & Senior Vice President, North America at Teva Pharmaceuticals and Board Member and Audit Committee Chairperson at Puretech Health. Sharon Barber-Lui holds Master Of Business Administration (M.B.A.), Concentration In Marketing And Corporate Entrepreneurship from Lehigh University College Of Business.
Email format at Teva Pharmaceuticals
This section adds company-level context without repeating Sharon Barber-Lui's masked contact details.
AeroLeads found 1 current-domain work email signal for Sharon Barber-Lui. Compare company email patterns before reaching out.
About Sharon Barber-Lui
It’s been an amazing ride so far. My career has taken me around the world and has given me the opportunity to work with incredibly talented people, and for that, I’m very grateful. With my passion for life science innovations, entrepreneurship and business transformations, my professional goals are to drive competitiveness and create value. Excitingly, I have just begun a new chapter and cannot wait to see what’s ahead.For the past 25 years, I have had the great fortune to serve in executive leadership roles in Commercialization, Finance, and Operations at large and emerging biopharmaceutical companies. Being able to spend 22 years at Merck in various roles was a gift. Having the opportunity to work across different disciplines, from Chief Financial Officer of US Oncology, leading the transformation of US Treasury Operations, and serving as Head of US Oncology Portfolio Strategy, Operations & Business Analytics, where I had the honor of scaling KEYTRUDA®, LYNPARZA®, and LENVIMA®, has been nothing short of amazing.Most recently, I served as Senior Vice President of Global Finance at EQRx, a biopharmaceutical company committed to innovative medicines for prevalent disease areas, providing financial leadership to create and scale the infrastructure and operational capabilities for growth and commercialization. In addition, I also serve as a Board Member, Audit Committee Chairperson, and Transaction Committee Member at PureTech Health plc.The most exciting aspect about running and building businesses is the potential to be market-disruptive and transformational. This requires agility, adability and creativity to navigate the unknowns. Success is dependent upon both the support and collaboration of dedicated and talented team members and boards.Speaking of team members, this is what makes it all worthwhile. I have built and scaled large and small teams to support start-ups, business transformations and strategy pivots. Whether it’s relationships with board members, auditors, bankers, investors, analysts, scientists or business partners, these relationships are what make it all possible. They support your vision, share your vision, build on your vision, and make the vision come to life.Excited for where the journey takes me!
Listed skills include Collaborative Leadership, Leadership Development, Project Execution, Process Improvement, and 10 others.
Sharon Barber-Lui's current company
Company context helps verify the profile and gives searchers a useful next step.
Sharon Barber-Lui work experience
A career timeline built from the work history available for this profile.
Chief Financial Officer & Senior Vice President, North America
Current
Board Member And Audit Committee Chairperson
CurrentSenior Vice President, Global Finance
Recruited in 2022 to serve as SVP of Global Finance and operational CFO to internationally scale public biotechnology company out of Cambridge, MA, building the infrastructure for future commercialization.► Financial & Budget Management: Increased monthly earnings on cash and investments by 100x by formulating and mobilizing an investment strategy. Provided financial oversight of $250M annual budget across commercial, manufacturing, research and development, and administrative functions.► SEC Compliance and Governance: Delivered and met all SEC reporting requirements, receiving “clean bill of health” in compliance with Sarbanes-Oxley requirements as large accelerated filer with a market cap of over $1B. Led all US SEC reporting including Form 10Ks, 10Qs, and S-filings.► Board of Directors Audit Committee Lead: Presented and led discussions on issues, trends and changes in the operating plan, and acted as the primary interface for accounting and reporting for the Company.► Risk Management: Managed the company’s risk profile, including benchmarking and obtaining appropriate levels of insurance, resulting in multi-million dollar annual savings.► Team Builder/Leader: Grew finance department by 50%, leading, coaching, and developing 20 members of the finance department, fostering functional excellence, enterprise thinking, and orchestrating a cohesive and high-performing team.
Head Of Us Oncology Portfolio Market Strategy, Operations & Business Analytics
Led portfolio market strategy and execution, as part of US Oncology executive leadership team, to achieve Merck’s ambitious and successful plan to be the #1 Oncology leader in the US, irrespective of international competitive threats, healthcare ecosystem changes, consumerism, pricing, and policy considerations. Led teams of Strategy, Marketing, Advanced Business Analytics, and Field Execution/Operations.► Transformed oncology brand marketing by creating a white glove experience for the medical community – physicians, distributors, health systems, and patients – generating demand and loyalty through a 360-degree, omni-channel experience.► Increased Annual Revenue by 30% moving for a top-tier customer account from #5 to #1 ranking by using public information data, analytics, and through cultivating relationships with key client decision-makers.► Drove operational excellence for new product launches leading to faster speed to market reducing historical cycle times by over 20%.► Architected and established Advanced Analytics team to create a competitive advantage in rapidly changing Oncology market by utilizing data science and machine learning.► Drove portfolio prioritization strategy by designing governance, framework, tools and monitoring processes to achieve laser focus of organizational resources to maximize portfolio performance and optimize customer experience.
Cfo, Us Oncology
Strategic Finance Partner for US Oncology Leadership Team and Advisor to US Oncology President.► Provided financial leadership for Merck’s US Oncology business which grew from $50M in 2014 to $5B in 2018 (publicly-available information), encompassing KEYTRUDA®, LYNPARZA®, LENVIMA®, EMEND® and other Oncology brands.► Negotiated multiple business development deals with annual revenues of $1B and devised positive terms to achieve an optimal financial and strategic deal that became the benchmark for future Oncology deals.► Led several cross-functional teams to enhance business performance reviews, develop dashboard reporting and improve operational efficiency and expense savings. Led headcount planning within Oncology that grew 10x in FTEs.
Regional Treasurer, Us Treasury Services
Group Treasurer of 30 US legal entities.► Spearheaded the transformation and consolidation of the US Treasury Operations and Services groups and achieved innovation and optimization of end-to-end processes, resulting in operational efficiency and team development.► Recognized as a leading change agent across Treasury, Tax, and Finance based on collaborative influence and business impact including the optimization of cash pooling structures with greater than $15B in cash within 4-week timeframe.
Director, Us Treasury Operations
US Operations Leader accountable for daily cash transactional activities of $10B+.► Formulated a cash management solution to encompass the settlement of $7B of foreign exchange contracts which achieved operational efficiencies by reducing FTE involvement by 30% and reducing business risk with elimination of manual calculations in previous process.► Envisaged and improved US cash operations, trade support, transactional systems, and processes that included over 30 systems, 100+ processes, and significant stakeholders.
Director, Global Treasury And Legal Entity Integration
Treasury Lead for Integration of $44B merger of Merck and Schering Plough legal entities. ► Led the US cash repatriation strategy from foreign subsidiaries by orchestrating a detailed dividend and communication plan, overcoming major organizational and legal entity obstacles.► Partnered with global stakeholders to plan and execute numerous, complex legal and financial transactions and restructurings impacting the consolidation of legal entities from the Merck and Schering Plough merger.► Designed and implemented a new automated SAP reporting solution to increase decision-making capability, reducing the report generation process by 50%, from 6 weeks to 3 weeks.
Regional Treasurer, Asia Pacific & Japan Treasury Services
Group Treasurer of 13 international subsidiaries for capital, financing, and liquidity management.► Led the development and execution of complex cash management, liquidity, and treasury strategies in Asia Pacific and Japan.► Spearheaded the Global Banking Initiative for 13 markets to implement a standardized payment interface and centralized collections and reconciliation process that realized an overall Treasury vision.► Realized $2M in annual benefits by evaluating, negotiating, and securing a lower cost for a major country's receivables factoring program through discussions with local and relationship bank contacts.
Director, Global Human Health Financial Services
Manager, Hr Financial Services And Executive Benefits
Manager, International Treasury Services
Sr. Financial Analyst, Worldwide Human Health Services
Financial Analyst, Corporate Financial Services
Supervising Senior Accountant
Sharon Barber-Lui education
Master Of Business Administration (M.B.A.), Concentration In Marketing And Corporate Entrepreneurship
Bachelor Of Science (B.S.), Accounting
Frequently asked questions about Sharon Barber-Lui
Quick answers generated from the profile data available on this page.
What company does Sharon Barber-Lui work for?
Sharon Barber-Lui works for Teva Pharmaceuticals.
What is Sharon Barber-Lui's role at Teva Pharmaceuticals?
Sharon Barber-Lui is listed as Chief Financial Officer and Senior Vice President, North America at Teva Pharmaceuticals.
What is Sharon Barber-Lui's email address?
AeroLeads has found 1 work email signal at @merck.com for Sharon Barber-Lui at Teva Pharmaceuticals.
Where is Sharon Barber-Lui based?
Sharon Barber-Lui is based in New York City Metropolitan Area, United States while working with Teva Pharmaceuticals.
What companies has Sharon Barber-Lui worked for?
Sharon Barber-Lui has worked for Teva Pharmaceuticals, Puretech Health, Eqrx, Merck, and Kpmg.
How can I contact Sharon Barber-Lui?
You can use AeroLeads to view verified contact signals for Sharon Barber-Lui at Teva Pharmaceuticals, including work email, phone, and LinkedIn data when available.
What schools did Sharon Barber-Lui attend?
Sharon Barber-Lui holds Master Of Business Administration (M.B.A.), Concentration In Marketing And Corporate Entrepreneurship from Lehigh University College Of Business.
What skills is Sharon Barber-Lui known for?
Sharon Barber-Lui is listed with skills including Collaborative Leadership, Leadership Development, Project Execution, Process Improvement, International Treasury, Liquidity Management, Financial Analysis, and Financial Planning.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial